Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
STAAR Surgical Reports Progress on Japanese Application for Approval of Visian(TM) Implantable Collamer(R) Lens (ICL(TM))
STAAR Surgical Generates Cash From Operations During Second Quarter ; Company Generates Cash From Operating Activities and EBITDA for First Time in More Than Six Years; Substantial Improvements in Operating Expense Management; Total Visian ICL(R) Market Share Increases As Units Grow 29%; Domestic IOL Progress: U.S. Silicone IOL Sales Increase 19%; Significant Regulatory Progress Evidenced By New Product Approvals; CAST Research Project Surpasses 200 Eyes
STAAR Surgical Generates Cash From Operations During Second Quarter
STAAR Surgical to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
STAAR Surgical Announces Second Quarter 2009 Earnings Release Date And Conference Call
Richard A. Meier Appointed to STAAR Surgical Board of Directors
STAAR Surgical Completes Common Stock Offering
STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System
STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System
STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System
STAAR Surgical Reports Significant First Quarter Progress
STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call
STAAR Surgical Releases Afinity(TM) Collamer(R) Aspheric Single Piece NTIOL
STAAR Surgical Reports 14% Fourth Quarter Revenue Growth
STAAR Surgical Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
STAAR Surgical Reports 33% Third Quarter Revenue Growth
STAAR Surgical Visian(TM) ICL Revenues Increase by 52% During Third Quarter
STAAR Surgical Announces Third Quarter 2008 Earnings Release Date and Conference Call
STAAR Surgical to Present at The Roth 'Best Ideas' Conference
STAAR Surgical to Present at the Noble Financial Equity Conference
STAAR Surgical's VISIAN ICL to be Featured on CBS 'Early Show'
STAAR Surgical to Present at BMO Capital Markets Focus on Heathcare Conference in New York
STAAR Surgical Reports 38% Second Quarter Revenue Growth
STAAR Surgical's Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification
STAAR Surgical Announces Second Quarter 2008 Earnings Release Date and Conference Call
Alternative to LASIK Increases Momentum with U.S. Consumers
STAAR Surgical's LASIK Alternative Expands U.S. Market Gains
STAAR Surgical Reports Solid First Quarter Progress - Jun 2 2008 4:44AM
STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call
More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch
STAAR Surgical Plans Major Presence at ASCRS
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
